
In-Home Medication
Integrating Multidisciplinary Perspectives in Design-Driven Pharma Practices
Series: Research for Development;
- Publisher's listprice EUR 53.49
-
The price is estimated because at the time of ordering we do not know what conversion rates will apply to HUF / product currency when the book arrives. In case HUF is weaker, the price increases slightly, in case HUF is stronger, the price goes lower slightly.
- Discount 8% (cc. 1 815 Ft off)
- Discounted price 20 874 Ft (19 880 Ft + 5% VAT)
22 690 Ft
Availability
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Why don't you give exact delivery time?
Delivery time is estimated on our previous experiences. We give estimations only, because we order from outside Hungary, and the delivery time mainly depends on how quickly the publisher supplies the book. Faster or slower deliveries both happen, but we do our best to supply as quickly as possible.
Product details:
- Edition number 2024
- Publisher Springer
- Date of Publication 24 December 2024
- Number of Volumes 1 pieces, Book
- ISBN 9783031532931
- Binding Hardback
- No. of pages556 pages
- Size 235x155 mm
- Language English
- Illustrations 139 Illustrations, black & white; 110 Illustrations, color 673
Categories
Short description:
This is an open access book.
This book provides a distinctive perspective on the daily utilization and consumption of medicines and drugs. It seamlessly integrates the research traditions of the medical and pharmaceutical realms with the approach of fostering the relationship between users and products, a characteristic of design and user studies. By applying a diverse range of expertise, the authors endeavor to reestablish the interconnectedness of issues that place the drug and the indispensable information for its use directly into the hands of the patient. The primary objective is to formulate an initial set of recommendations and compile a repertoire of best practices. Consequently, this book becomes an indispensable resource for students, professionals, and academics engaged in design culture, as well as those operating within the healthcare domain, such as the pharmaceutical industry, medical practitioners, and pharmacists. It is equally valuable for individuals working in institutions responsible for regulating medicines and overseeing their presence in the market. As a comprehensive guide, this book serves as an essential read, offering insights that bridge the gap between various sectors involved in the intricate landscape of medicine and drug consumption.
MoreLong description:
This is an open access book.
This book provides a distinctive perspective on the daily utilization and consumption of medicines and drugs. It seamlessly integrates the research traditions of the medical and pharmaceutical realms with the approach of fostering the relationship between users and products, a characteristic of design and user studies. By applying a diverse range of expertise, the authors endeavor to reestablish the interconnectedness of issues that place the drug and the indispensable information for its use directly into the hands of the patient. The primary objective is to formulate an initial set of recommendations and compile a repertoire of best practices. Consequently, this book becomes an indispensable resource for students, professionals, and academics engaged in design culture, as well as those operating within the healthcare domain, such as the pharmaceutical industry, medical practitioners, and pharmacists. It is equally valuable for individuals working in institutions responsible for regulating medicines and overseeing their presence in the market. As a comprehensive guide, this book serves as an essential read, offering insights that bridge the gap between various sectors involved in the intricate landscape of medicine and drug consumption.
MoreTable of Contents:
1 Towards in-home medication: Medicinal products as daily objects.- Part 1 Objects of science: the pharmaceutical industry as a place of preciseness.- 2 Medicine packaging legislation and its evolution according to technological innovation for better healthcare support.- Addendum 1 ? Regulatory references. - 3 Primary medicine packaging and quality control.- 4 Pharmaceutical forms and primary packaging: a glossary.- 5 Secondary packaging of medicines: design processes for the pharmaceutical industry.- 6 Secondary packaging and leaflets: a glossary.- Part 2 Prescribing and dispensing: accompanying the patient to the correct use of medicines.- 7 Moving the care process in the in-home context: the therapeutic prescription.- 8 Dispensing medicines: A necessary link between doctor and patient.- 9 The future digital pharmacological prescription between therapy adherence and integrated healthcare personal plans.- 10 Navigating the complexities of the OTC medicine ecosystem.- 11 Dealing with medicines through online platforms and communities.- Addendum 2 ? Medication errors data.- Part 3 The daily life as a place of inaccuracy - the domesticity of therapy.- 12 Medicines as designed objects.- 13 The in-home place of medications: perspectives of domestication.- 14 In-home: Medicinals treatment as a learning process.- 15 Use phenomenologies. Observing the user while taking pharmaceutical therapies.- 16 Use phenomenologies. Oral solid forms in blister packs.- 17 Use phenomenologies. What does the user do with the secondary medicine packaging and package leaflet?.- Part 4 - The pharmaceutical product system: premises for the definition of a repertory of good practices.- 18 How political and cultural challenges are impacting pharma industries.- 19 Medicinal products: when innovation meets the patient.- 20 Pharmaceutical packaging according to the ?Packaging Ethics Charter?.- 21 Sensory qualities of the medicines: from problems to proposals.- 22 Compendium: step toward design-oriented practices in the pharma industry in a multidisciplinary perspective.- Addendum 3 The name of medicines. LASA medicines.- Addendum 4 ? Methods of user involvement.- Addendum 5 ? Error Reporting Procedures.
More